Literature DB >> 26888280

Low vitamin D levels and non-alcoholic fatty liver disease, evidence for their independent association in men in East China: a cross-sectional study (Survey on Prevalence in East China for Metabolic Diseases and Risk Factors (SPECT-China)).

Hua-Ling Zhai1, Ning-Jian Wang1, Bing Han1, Qin Li1, Yi Chen1, Chun-Fang Zhu1, Ying-Chao Chen1, Fang-Zhen Xia1, Zhen Cang1, Chao-Xia Zhu1, Meng Lu1, Ying-Li Lu1.   

Abstract

Recent studies have suggested an association between vitamin D and non-alcoholic fatty liver disease (NAFLD); however, some results are subject to debate. This study was carried out to evaluate the correlation between NAFLD and vitamin D in men and women in East China. The data were obtained from a cross-sectional study that focused on the health and metabolic status of adults in sixteen areas of East China. According to ultrasonic assessments, the patients were divided into normal and NAFLD groups. Demographic characteristics and biochemical measurements were obtained. Binary logistic regression analysis was used to explore the association. In total, 5066 subjects were enrolled, and 2193 (43·3 %) were diagnosed with NAFLD; 84·56 % of the subjects showed vitamin D deficiency. Subjects with high vitamin D levels had a lower prevalence of NAFLD, particularly male subjects. Within the highest quartile of vitamin D levels, the prevalence of NAFLD was 40·8 %, whereas the lowest quartile of vitamin D levels showed a prevalence of 62·2 %, which was unchanged in women across the vitamin D levels. Binary logistic analysis showed that decreased vitamin D levels were associated with an increased risk of NAFLD (OR 1·54; 95 % CI 1·26, 1·88). This study suggests that vitamin D levels are significantly associated with NAFLD and that vitamin D acts as an independent factor for NAFLD prevalence, particularly in males in East China. Vitamin D interventional treatment might be a new target for controlling NAFLD; elucidating the mechanism requires further research.

Entities:  

Keywords:  25(OH)D3zzm321990 25-hydroxyvitamin D3; BMI; HOMA-IR homoeostatic model assessment for insulin resistance; HbA1c glycated Hb; Homoeostasis model assessment; Insulin resistance; NAFLD non-alcoholic fatty liver disease; Non-alcoholic fatty liver disease; US ultrasonography; VDD vitamin D deficiency; Vitamin D

Mesh:

Substances:

Year:  2016        PMID: 26888280     DOI: 10.1017/S0007114516000386

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  21 in total

Review 1.  Nonalcoholic fatty liver disease in Asia: emerging perspectives.

Authors:  Wai-Kay Seto; Man-Fung Yuen
Journal:  J Gastroenterol       Date:  2016-09-16       Impact factor: 7.527

2.  Vitamin D signaling maintains intestinal innate immunity and gut microbiota: potential intervention for metabolic syndrome and NAFLD.

Authors:  Yilan Zeng; Mei Luo; Liwei Pan; Yuan Chen; Siqi Guo; Dongxia Luo; Li Zhu; Yong Liu; Lisha Pan; Siya Xu; Ruofei Zhang; Chunyan Zhang; Pengfei Wu; Liangpeng Ge; Mazen Noureddin; Stephen J Pandol; Yuan-Ping Han
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-27       Impact factor: 4.052

Review 3.  Sarcopenia and fatty liver disease.

Authors:  Jung A Kim; Kyung Mook Choi
Journal:  Hepatol Int       Date:  2019-11-08       Impact factor: 6.047

4.  Low vitamin D status is associated with advanced liver fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Bing-Bing Yang; Yuan-Hua Chen; Cheng Zhang; Chang-E Shi; Kai-Feng Hu; Ju Zhou; De-Xiang Xu; Xi Chen
Journal:  Endocrine       Date:  2016-10-31       Impact factor: 3.633

5.  Association between non-alcoholic fatty liver disease and bone turnover markers in southwest China.

Authors:  Ying Liu; Ping Shuai; Yuping Liu; Dongyu Li
Journal:  J Bone Miner Metab       Date:  2022-05-31       Impact factor: 2.626

6.  Association and interaction between vitamin D level and metabolic syndrome for non-alcoholic fatty liver disease.

Authors:  Salam Bennouar; Abdelghani Bachir Cherif; Amel Kessira; Djamel Eddine Bennouar; Samia Abdi
Journal:  J Diabetes Metab Disord       Date:  2021-07-21

7.  Attenuating the rate of total body fat accumulation and alleviating liver damage by oral administration of vitamin D-enriched edible mushrooms in a diet-induced obesity murine model is mediated by an anti-inflammatory paradigm shift.

Authors:  A Drori; D Rotnemer-Golinkin; S Avni; A Drori; O Danay; D Levanon; J Tam; L Zolotarev; Y Ilan
Journal:  BMC Gastroenterol       Date:  2017-11-28       Impact factor: 3.067

8.  The Association between Vitamin D Insufficiency and Nonalcoholic Fatty Liver Disease: A Population-Based Study.

Authors:  Yeonjung Ha; Seong Gyu Hwang; Kyu Sung Rim
Journal:  Nutrients       Date:  2017-07-27       Impact factor: 5.717

9.  Vitamin D Levels Are Inversely Associated with Liver Fat Content and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Middle-Aged and Elderly Population: The Shanghai Changfeng Study.

Authors:  Dan Wang; Huandong Lin; Mingfeng Xia; Qiqige Aleteng; Xiaoming Li; Hui Ma; Baishen Pan; Jian Gao; Xin Gao
Journal:  PLoS One       Date:  2016-06-10       Impact factor: 3.240

Review 10.  Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future.

Authors:  Ilaria Barchetta; Flavia Agata Cimini; Maria Gisella Cavallo
Journal:  Nutrients       Date:  2017-09-14       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.